| Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study AB Docherty, EM Harrison, CA Green, HE Hardwick, R Pius, L Norman, ... bmj 369, 2020 | 3066 | 2020 |
| Genetic mechanisms of critical illness in COVID-19 E Pairo-Castineira, S Clohisey, L Klaric, AD Bretherick, K Rawlik, D Pasko, ... Nature 591 (7848), 92-98, 2021 | 1122 | 2021 |
| Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19 Y Peng, AJ Mentzer, G Liu, X Yao, Z Yin, D Dong, W Dejnirattisai, ... Nature immunology 21 (11), 1336-1345, 2020 | 1068 | 2020 |
| Respiratory syncytial virus A Jha, H Jarvis, C Fraser, P Openshaw SARS, MERS and other viral lung infections, 2016 | 1016 | 2016 |
| Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score SR Knight, A Ho, R Pius, I Buchan, G Carson, TM Drake, J Dunning, ... bmj 370, 2020 | 865 | 2020 |
| IFITM3 restricts the morbidity and mortality associated with influenza AR Everitt, S Clare, T Pertel, SP John, RS Wash, SE Smith, CR Chin, ... Nature 484 (7395), 519-523, 2012 | 795 | 2012 |
| SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ... Cell 185 (3), 467-484. e15, 2022 | 694 | 2022 |
| Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. P Openshaw, EE Murphy, NA Hosken, V Maino, K Davis, K Murphy, ... The Journal of experimental medicine 182 (5), 1357-1367, 1995 | 671 | 1995 |
| Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study OV Swann, KA Holden, L Turtle, L Pollock, CJ Fairfield, TM Drake, S Seth, ... bmj 370, 2020 | 638 | 2020 |
| Bronchiolitis RL Smyth, PJM Openshaw The lancet 368 (9532), 312-322, 2006 | 591 | 2006 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 580 | 2021 |
| Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. MJ Cannon, PJ Openshaw, BA Askonas The Journal of experimental medicine 168 (3), 1163-1168, 1988 | 553 | 1988 |
| Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. E Murphy, K Shibuya, N Hosken, P Openshaw, V Maino, K Davis, ... The Journal of experimental medicine 183 (3), 901-913, 1996 | 536 | 1996 |
| Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity EC Thomson, LE Rosen, JG Shepherd, R Spreafico, A da Silva Filipe, ... Cell 184 (5), 1171-1187. e20, 2021 | 519 | 2021 |
| Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol AB Docherty, EM Harrison, CA Green, H Hardwick, R Pius, L Norman, ... MedRxiv, 2020.04. 23.20076042, 2020 | 433 | 2020 |
| Tracheostomy in the COVID-19 era: global and multidisciplinary guidance BA McGrath, MJ Brenner, SJ Warrillow, V Pandian, A Arora, TS Cameron, ... The Lancet Respiratory Medicine 8 (7), 717-725, 2020 | 422 | 2020 |
| Immune responses and disease enhancement during respiratory syncytial virus infection PJM Openshaw, JS Tregoning Clinical microbiology reviews 18 (3), 541-555, 2005 | 417 | 2005 |
| Distinct types of lung disease caused by functional subsets of antiviral T cells. WH Alwan, WJ Kozlowska, PJ Openshaw The Journal of experimental medicine 179 (1), 81-89, 1994 | 399 | 1994 |
| Inhibition of tumor necrosis factor reduces the severity of virus‐specific lung immunopathology T Hussell, A Pennycook, PJM Openshaw European journal of immunology 31 (9), 2566-2573, 2001 | 380 | 2001 |
| ISARIC4C investigators. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study AB Docherty, EM Harrison, CA Green, HE Hardwick, R Pius, L Norman, ... Bmj 369, m1985, 2020 | 364 | 2020 |
Malcolm G SempleProfessor of Child Health and Outbreak Medicine, University of Liverpool在 liverpool.ac.uk 的电子邮件经过验证
